Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial

Hypofractionated radiotherapy is the standard of care for adjuvant whole breast radiotherapy (RT). However, adoption has been slow. The indication for regional nodal irradiation has been expanded to include patients with 0-3 involved lymph nodes. We investigated the impact of the publication of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Krug, David (Author) , Vonthein, Reinhard (Author) , Schreiber, Andreas (Author) , Boicev, Alexander D. (Author) , Zimmer, Jörg (Author) , Laubach, Reinhold (Author) , Weidner, Nicola (Author) , Dinges, Stefan (Author) , Hipp, Matthias (Author) , Schneider, Ralf (Author) , Weinstrauch, Evelyn (Author) , Martin, Thomas (Author) , Hörner-Rieber, Juliane (Author) , Olbrich, Denise (Author) , Illen, Alicia (Author) , Heßler, Nicole (Author) , König, Inke R. (Author) , Dellas, Kathrin (Author) , Dunst, Jürgen (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Strahlentherapie und Onkologie
Year: 2021, Volume: 197, Issue: 9, Pages: 802-811
ISSN:1439-099X
DOI:10.1007/s00066-020-01730-9
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-020-01730-9
Get full text
Author Notes:David Krug, Reinhard Vonthein, Andreas Schreiber, Alexander D. Boicev, Jörg Zimmer, Reinhold Laubach, Nicola Weidner, Stefan Dinges, Matthias Hipp, Ralf Schneider, Evelyn Weinstrauch, Thomas Martin, Juliane Hörner-Rieber, Denise Olbrich, Alicia Illen, Nicole Heßler, Inke R. König, Kathrin Dellas, Jürgen Dunst

MARC

LEADER 00000caa a2200000 c 4500
001 1869552172
003 DE-627
005 20240331080301.0
007 cr uuu---uuuuu
008 231107s2021 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00066-020-01730-9  |2 doi 
035 |a (DE-627)1869552172 
035 |a (DE-599)KXP1869552172 
035 |a (OCoLC)1425217385 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Krug, David  |e VerfasserIn  |0 (DE-588)1062940202  |0 (DE-627)807054747  |0 (DE-576)420297944  |4 aut 
245 1 0 |a Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial  |c David Krug, Reinhard Vonthein, Andreas Schreiber, Alexander D. Boicev, Jörg Zimmer, Reinhold Laubach, Nicola Weidner, Stefan Dinges, Matthias Hipp, Ralf Schneider, Evelyn Weinstrauch, Thomas Martin, Juliane Hörner-Rieber, Denise Olbrich, Alicia Illen, Nicole Heßler, Inke R. König, Kathrin Dellas, Jürgen Dunst 
264 1 |c 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 15 Dezember 2020 
500 |a Gesehen am 7.11.2023 
520 |a Hypofractionated radiotherapy is the standard of care for adjuvant whole breast radiotherapy (RT). However, adoption has been slow. The indication for regional nodal irradiation has been expanded to include patients with 0-3 involved lymph nodes. We investigated the impact of the publication of the updated German S3 guidelines in 2017 on adoption of hypofractionation and enrollment of patients with lymph node involvement within a randomized controlled phase III trial. 
650 4 |a Breast cancer 
650 4 |a Guideline implementation 
650 4 |a Hypofractionation 
650 4 |a Radiotherapy 
700 1 |a Vonthein, Reinhard  |e VerfasserIn  |4 aut 
700 1 |a Schreiber, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Boicev, Alexander D.  |d 1970-  |e VerfasserIn  |0 (DE-588)12098248X  |0 (DE-627)705136795  |0 (DE-576)292480679  |4 aut 
700 1 |a Zimmer, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Laubach, Reinhold  |e VerfasserIn  |4 aut 
700 1 |a Weidner, Nicola  |e VerfasserIn  |4 aut 
700 1 |a Dinges, Stefan  |d 1957-  |e VerfasserIn  |0 (DE-588)121402703  |0 (DE-627)705435865  |0 (DE-576)166342742  |4 aut 
700 1 |a Hipp, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Schneider, Ralf  |e VerfasserIn  |4 aut 
700 1 |a Weinstrauch, Evelyn  |d 1971-  |e VerfasserIn  |0 (DE-588)130817929  |0 (DE-627)707574641  |0 (DE-576)298357267  |4 aut 
700 1 |a Martin, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Hörner-Rieber, Juliane  |d 1985-  |e VerfasserIn  |0 (DE-588)1025307631  |0 (DE-627)722020511  |0 (DE-576)370188039  |4 aut 
700 1 |a Olbrich, Denise  |e VerfasserIn  |4 aut 
700 1 |a Illen, Alicia  |e VerfasserIn  |4 aut 
700 1 |a Heßler, Nicole  |e VerfasserIn  |4 aut 
700 1 |a König, Inke R.  |d 1972-  |e VerfasserIn  |0 (DE-588)124625088  |0 (DE-627)363452796  |0 (DE-576)294418598  |4 aut 
700 1 |a Dellas, Kathrin  |e VerfasserIn  |0 (DE-588)124915639  |0 (DE-627)368072134  |0 (DE-576)294566902  |4 aut 
700 1 |a Dunst, Jürgen  |d 1958-  |e VerfasserIn  |0 (DE-588)172057892  |0 (DE-627)696962179  |0 (DE-576)132932237  |4 aut 
773 0 8 |i Enthalten in  |t Strahlentherapie und Onkologie  |d Berlin : Springer Medizin, 1997  |g 197(2021), 9, Seite 802-811  |h Online-Ressource  |w (DE-627)312407866  |w (DE-600)2003907-4  |w (DE-576)090884809  |x 1439-099X  |7 nnas  |a Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial 
773 1 8 |g volume:197  |g year:2021  |g number:9  |g pages:802-811  |g extent:10  |a Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial 
856 4 0 |u https://doi.org/10.1007/s00066-020-01730-9  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20231107 
993 |a Article 
994 |a 2021 
998 |g 1025307631  |a Hörner-Rieber, Juliane  |m 1025307631:Hörner-Rieber, Juliane  |d 910000  |d 911400  |d 50000  |e 910000PH1025307631  |e 911400PH1025307631  |e 50000PH1025307631  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 13 
999 |a KXP-PPN1869552172  |e 4403772315 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"recId":"312407866","pubHistory":["Nachgewiesen 173.1997 -"],"origin":[{"publisherPlace":"Berlin ; Heidelberg ; [München]","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Medizin ; Urban & Vogel"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["ger"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"10","year":"2021","pages":"802-811","text":"197(2021), 9, Seite 802-811","volume":"197","issue":"9"},"disp":"Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trialStrahlentherapie und Onkologie","note":["Gesehen am 13.05.09"],"id":{"issn":["1439-099X"],"zdb":["2003907-4"],"eki":["312407866"]},"title":[{"title":"Strahlentherapie und Onkologie","title_sort":"Strahlentherapie und Onkologie","subtitle":"journal of radiation oncology, biology, physics"}]}],"physDesc":[{"extent":"10 S."}],"person":[{"display":"Krug, David","role":"aut","given":"David","family":"Krug","roleDisplay":"VerfasserIn"},{"given":"Reinhard","display":"Vonthein, Reinhard","role":"aut","roleDisplay":"VerfasserIn","family":"Vonthein"},{"given":"Andreas","display":"Schreiber, Andreas","role":"aut","family":"Schreiber","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Boicev","display":"Boicev, Alexander D.","role":"aut","given":"Alexander D."},{"display":"Zimmer, Jörg","role":"aut","given":"Jörg","roleDisplay":"VerfasserIn","family":"Zimmer"},{"family":"Laubach","roleDisplay":"VerfasserIn","given":"Reinhold","display":"Laubach, Reinhold","role":"aut"},{"role":"aut","display":"Weidner, Nicola","given":"Nicola","roleDisplay":"VerfasserIn","family":"Weidner"},{"roleDisplay":"VerfasserIn","family":"Dinges","given":"Stefan","display":"Dinges, Stefan","role":"aut"},{"family":"Hipp","roleDisplay":"VerfasserIn","display":"Hipp, Matthias","role":"aut","given":"Matthias"},{"given":"Ralf","role":"aut","display":"Schneider, Ralf","family":"Schneider","roleDisplay":"VerfasserIn"},{"given":"Evelyn","display":"Weinstrauch, Evelyn","role":"aut","roleDisplay":"VerfasserIn","family":"Weinstrauch"},{"family":"Martin","roleDisplay":"VerfasserIn","given":"Thomas","display":"Martin, Thomas","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Hörner-Rieber","role":"aut","display":"Hörner-Rieber, Juliane","given":"Juliane"},{"given":"Denise","display":"Olbrich, Denise","role":"aut","roleDisplay":"VerfasserIn","family":"Olbrich"},{"roleDisplay":"VerfasserIn","family":"Illen","given":"Alicia","role":"aut","display":"Illen, Alicia"},{"family":"Heßler","roleDisplay":"VerfasserIn","role":"aut","display":"Heßler, Nicole","given":"Nicole"},{"display":"König, Inke R.","role":"aut","given":"Inke R.","family":"König","roleDisplay":"VerfasserIn"},{"display":"Dellas, Kathrin","role":"aut","given":"Kathrin","roleDisplay":"VerfasserIn","family":"Dellas"},{"display":"Dunst, Jürgen","role":"aut","given":"Jürgen","roleDisplay":"VerfasserIn","family":"Dunst"}],"name":{"displayForm":["David Krug, Reinhard Vonthein, Andreas Schreiber, Alexander D. Boicev, Jörg Zimmer, Reinhold Laubach, Nicola Weidner, Stefan Dinges, Matthias Hipp, Ralf Schneider, Evelyn Weinstrauch, Thomas Martin, Juliane Hörner-Rieber, Denise Olbrich, Alicia Illen, Nicole Heßler, Inke R. König, Kathrin Dellas, Jürgen Dunst"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"2021"}],"language":["eng"],"note":["Online veröffentlicht: 15 Dezember 2020","Gesehen am 7.11.2023"],"recId":"1869552172","id":{"eki":["1869552172"],"doi":["10.1007/s00066-020-01730-9"]},"title":[{"title":"Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial","title_sort":"Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial"}]} 
SRT |a KRUGDAVIDVIMPACTOFGU2021